Invesco Ltd. trimmed its holdings in shares of Dolby Laboratories (NYSE:DLB - Free Report) by 50.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 132,042 shares of the electronics maker's stock after selling 134,227 shares during the quarter. Invesco Ltd. owned approximately 0.14% of Dolby Laboratories worth $10,604,000 as of its most recent SEC filing.
Several other institutional investors also recently bought and sold shares of DLB. Alpine Bank Wealth Management purchased a new position in Dolby Laboratories during the first quarter valued at approximately $25,000. Cheviot Value Management LLC purchased a new position in Dolby Laboratories during the first quarter valued at approximately $27,000. Global X Japan Co. Ltd. purchased a new position in Dolby Laboratories during the first quarter valued at approximately $51,000. Fifth Third Bancorp increased its holdings in Dolby Laboratories by 84.7% during the first quarter. Fifth Third Bancorp now owns 665 shares of the electronics maker's stock valued at $53,000 after buying an additional 305 shares during the period. Finally, UMB Bank n.a. increased its holdings in Dolby Laboratories by 170.5% during the first quarter. UMB Bank n.a. now owns 698 shares of the electronics maker's stock valued at $56,000 after buying an additional 440 shares during the period. 58.56% of the stock is owned by hedge funds and other institutional investors.
Insider Transactions at Dolby Laboratories
In other news, SVP Shriram Revankar sold 7,000 shares of Dolby Laboratories stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $74.92, for a total transaction of $524,440.00. Following the completion of the sale, the senior vice president directly owned 70,435 shares in the company, valued at approximately $5,276,990.20. The trade was a 9.04% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Mark Andrew Sherman sold 15,000 shares of Dolby Laboratories stock in a transaction on Wednesday, June 4th. The stock was sold at an average price of $75.02, for a total transaction of $1,125,300.00. Following the sale, the executive vice president owned 62,397 shares of the company's stock, valued at $4,681,022.94. The trade was a 19.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 148,049 shares of company stock worth $11,045,581. Company insiders own 38.39% of the company's stock.
Dolby Laboratories Stock Performance
DLB traded down $0.46 during trading on Friday, hitting $71.68. The stock had a trading volume of 400,469 shares, compared to its average volume of 473,551. The company has a market capitalization of $6.87 billion, a PE ratio of 26.26 and a beta of 0.91. Dolby Laboratories has a twelve month low of $68.24 and a twelve month high of $89.66. The stock has a 50 day simple moving average of $74.24 and a two-hundred day simple moving average of $76.22.
Dolby Laboratories (NYSE:DLB - Get Free Report) last announced its earnings results on Thursday, July 31st. The electronics maker reported $0.78 earnings per share for the quarter, beating the consensus estimate of $0.72 by $0.06. The company had revenue of $315.55 million during the quarter, compared to the consensus estimate of $305.23 million. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. Dolby Laboratories's revenue was up 9.2% compared to the same quarter last year. During the same period last year, the firm earned $0.71 earnings per share. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. On average, equities research analysts anticipate that Dolby Laboratories will post 2.94 EPS for the current year.
Dolby Laboratories Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, August 20th. Stockholders of record on Tuesday, August 12th were paid a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 1.8%. The ex-dividend date was Tuesday, August 12th. Dolby Laboratories's payout ratio is presently 48.35%.
Wall Street Analysts Forecast Growth
Several equities analysts recently issued reports on the stock. Tigress Financial lifted their price objective on shares of Dolby Laboratories from $112.00 to $114.00 and gave the company a "buy" rating in a report on Friday, August 15th. Wall Street Zen upgraded shares of Dolby Laboratories from a "hold" rating to a "buy" rating in a research note on Saturday. Rosenblatt Securities restated a "buy" rating and issued a $95.00 target price on shares of Dolby Laboratories in a research note on Friday, August 1st. Finally, Barrington Research restated an "outperform" rating and issued a $100.00 target price on shares of Dolby Laboratories in a research note on Friday, May 2nd. Three analysts have rated the stock with a Buy rating, According to MarketBeat.com, Dolby Laboratories currently has an average rating of "Buy" and a consensus price target of $103.00.
View Our Latest Stock Report on Dolby Laboratories
Dolby Laboratories Profile
(
Free Report)
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
See Also

Before you consider Dolby Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.
While Dolby Laboratories currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.